ROIVANT SCIENCES LTD
ROIVNASDAQ🏆 #391 by market capUS Equity
$78.09▼ $5.40 (−6.92%)
Simulated price1h—
24h▼ 6.9%
7d—
14d—
30d—
1y—
🏦Market Cap
$25.84B
Mid Cap
📈Revenue Growth (YoY)
-67.6%
Declining
📊Gross Margin
81.2%
High
💵FCF Margin
—
⚖️P/S Ratio
3431.3x
Expensive
Otter Score
43
Weak
No chart data available for ROIV.
Trading Snapshot
- Day Range
- $77.69 – $78.81
- 52-Week Range
- $10.90 – $37.00
- Volume
- $2.65B
- Avg Volume
- $2.15B
- Shares Outstanding
- 722.4M
- Next Earnings
- Sep 17, 2026
Fundamentals Snapshot
- Annual Revenue
- $8M
- Last Q Revenue
- $2M
- P/E Ratio
- —
- P/S Ratio
- 3431.3x
- EPS (TTM)
- $-0.39
- Dividend Yield
- —
Why Investors Own ROIV
- ✓High-growth profile — revenue up +45.0% YoY with expanding US Equity exposure.
- ✓Healthy economics — 66% gross margin and 18% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$8M▲ +44.8% YoY
Gross Margin (TTM)
65.7%▲ +3.8% YoY
Operating Income (TTM)
$3M▲ +44.8% YoY
Free Cash Flow (TTM)
$1M▲ +44.8% YoY
About ROIVANT SCIENCES LTD
A company profile for ROIVANT SCIENCES LTD isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
43/100
Analyst Price Target
ⓘAverage Target
$78.86
▲ +1.0% Upside
High Target$89.59
Low Target$62.93
Based on 30 analysts
Latest News & Updates
🚀
Bloomberg·2h ago
ROIVANT SCIENCES LTD tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
CNBC·5h ago
Analysts lift ROIV price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Barron’s·1d ago
ROIVANT SCIENCES LTD announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.